Toxoplasmosis - Literature review (1997 to 2000);Toxoplasmose - Levantamento bibliográfico de 1997 a 2000

Arquivos Brasileiros de Oftalmologia

Volumn 64, Issue 3, 2001, Pages 263-270

  Silveira, Cláudio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45449083275     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492001000300020     Document Type: Review

References (66)

1. Wilder HC. Toxoplasma chorioretinitis in adults. Arch Ophthalmol 1952;48:127-36.
2. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57:1.
3. Akstein RB, Wilson LA, Teutsch SM. Acquired toxoplasmosis. Am Acad Ophthalmol 1982;89:1299-302.
4. Green R. Histopathology of ocular toxoplasmosis. In: Bialasiewicz AA, Schaal KP. Infectious diseases of theeye. Holanda: Aeolus; 1994. p. 454-61.
5. Silveira C, Belfort Jr R, Burnier Jr M. Toxoplasmose ocular. Identificação de cistos de Toxoplasma gondii na retina de irmãos não gêmeos com diagnóstico de toxoplasmose ocular recidivante: primeiro caso mundial. Arq Bras Oftalmol 1987;50:215-8.
6. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Jr M, Silveira S et al. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 1992;14:136-44.
7. Belfort Jr R, Silveira C, Muccioli C, Abreu MT, Martins MC, Victora C. Incidence of acquired ocular toxoplasmosis seroconversion and clinical course in a prospective study (7 year follow up). [abstract 2019 ] Invest Ophthalmol and Vis Sci 1999;40(4 Suppl):383.
8. Altintas N, Kuman HA, Akisu C, Aksoy U, Atambay M. Toxoplasmosis in last four years in Agean region, Turkey. J Egipt Soc Parasitol 1997;27:439-43.
9. Joshi YR, Vyas S, Joshi KR. Seroprevalence of toxoplasmosis in Jodhpur, India. J Commun Dis 1998;30:32-7.
10. Jain SD, Uppal B, Mehta DK. Seroepidemiology of ocular toxoplasmosisprofile of an urban population. Indian J Pathol Microbiol 1998;41:387-90.
11. Abreu MT, Boni D, Belfort Jr R, Passos A, Garcia AR, Muccioli C et al. Toxoplasmose ocular em Venda Nova do Imigrante, ES, Brasil. Arq Bras Oftalmol 1998;61:540-5.
12. Garcia JL, Navarro IT, Ogawa L, Oliveira RC, de Kobilka E. Seroprevalence, epidemiology and ocular evaluation of human toxoplasmosis in the rural zone Jaguapita (Parana) Brazil. Rev Panam Salud Publica 1999;6:157-63.
13. Gilbert RE, Dunn DT, Lightman S, Murray PI, Pavesio CE, Gormley PD et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999;123:283-9.
14. Oréfice F. Prevalência da toxoplasmose ocular em Campos dos Goitacazes, RJ. Estudo Interinstitucional 1999. In: Oréfice F. Uveíte clínica e cirúrgica. Rio de Janeiro: Cultura Médica; 2000. v. 2.
15. Kamiyama M, Yamamoto S, Hayasaka S. Right active retinitis and left focal retinochoroidal scar in a girl with congenital toxoplasmosis. Ophthalmologica 1997;211:95-7.
16. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1997;123:1-16.
17. Melamed J, Kruter DW, Dornelles F. Alterações cerebrais e oculares na toxoplasmose congênita: estudo preliminar. [resumo 50]. Arq Bras Oftalmol 1998;61:418.
18. Ianaguihara EM, Spera CA, Moraes NSB, Guia T. Toxoplasmose ocular congênita bilateral em gêmeas univitelinas.[resumo 32]. Arq Bras Oftalmol 1998;61:410.
19. Malm G, Tear Fahnehjelm K, Wiklund S, Engman ML, Ivarsson SA, Petersson K, et al. Three children with congenital toxoplasmosis: early report from a Swedish prospective screening study. [commented on Acta Paediatr 1999; 88:586-8] Acta Paediatr 1999;88:667-70.
20. O'Neil JF. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis. Trans Am Ophthalmol Soc 1998;96:813-79.
21. Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998;105:1032-7.
22. Pereira M de F, Silva DA, Ferro EA, Mineo JR. Acquired and congenital ocular toxoplasmosis experimentally induced in Calomys callosus (Rodentia, Cricetidae). Mem Inst Oswaldo Cruz 1999;94:103-14.
23. Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 1999;84:224-6.
24. Holland GN, Muccioli C, Silveira C, Weisz JM, Belfort Jr. R, O'Connor R. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol 1999; 128:413-20.
25. Yamamoto JH, Vallochi AL, Silveira C, Kalil Filho J, Nussenblatt RB, Cunha-Neto E, et al. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis 2000;181:2018-22.
26. Joag SV, Li Z, Foresman L, Pinson DM, Raghavan R, Zhuge W, et al. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res Hum Retroviruses 1997;13: 635-45.
27. Arevalo JF, Quiceno JI, Garcia RF, McCutchan JA, Munguia D, Nelson JA, et al. Retinal findings and characteristics in AIDS patients with sistemic Micobacterium avium-intracellulare complex and toxoplasmic encephalitis. Ophthalmics Surg Lasers 1997;28:50-4.
28. Girard B, Prevost-Moravia G, Courpotin C, Lasfargues G. Ophthalmologic manifestations observed in a pediatric HIV-seropositive population. J Fr Ophthalmol 1997;20:49-60.
29. Lanjewar DN, Surve KV, Maheshwari MB, Shenoy BP, Hira SK. Toxoplasmosis in the central nervous system in the acquired immunodeficiency syndrome. Indian J Pathol Microbiol 1998;41:147-51.
30. Chakraborty J. HIV/AIDS and ocular manifestations. J Indian Med Assoc 1999;97:299-304.
31. McHugh TD, Bathgate T, Mangan J, Johnson JD, Holliman RE, Butcher PD. Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis. J Med Microbiol 1997;46:587-95.
32. Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR. Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 1998;82:1017-21.
33. Gomez Marin JE, Pinon JM, Bonhomme A, Guenounou M. Does human toxoplasmosis involve an imbalance in T1/T2 cytokines? Med Hypotheses 1997;48:161-9.
34. Lappin MR, Dow SW, Reif JS, Chavkin MJ. Elevated interleukin 6 activity in aqueous humor of cats with uveitis. Vet Immunol Immunopathol 1997;58:17-26.
35. Danise A, Cinque P, Vergani S, Candino M, Racca S, De Bona A, Novati R, Castagna A. Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus. Clin Infect Dis 1997;24:1100-6.
36. Bornand JE, de Gottrau P. Uveitis: is ocular toxoplasmosis only a clinical diagnosis? Ophthalmologica 1997:211:87-9.
37. Quentin CD, Reiber H. Analysis of aqueous humor in intraocular toxoplasmosis]. [commented on Ophthalmologe 1998;95:120-1]. Ophthalmologe 1997;94:728-31.
38. Bernasconi O, Auer C, Herbort CP. Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm 1997;5:207-11.
39. Garweg JG, Jacquier P, Fluckiger F. Current limits in a diagnosis of ocular toxoplasmosis. Klin Monatsbl Augenheilkd 1998;212:330-3.
40. Ongkosuwito JV, Feron EJ, van Doornik CE, Van der Lelij A, Hoyng CB, La Heij EC, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 1998;39:2659-65.
41. Burney DP, Chavkin MJ, Dow SW, Potter TA, Lappin MR. Polymerase chain reaction for the detection of Toxoplasma gondii within aqueous humor of experimentally-inoculated cats. Vet Parasitol 1998;79:181-6.
42. Klaren VN, Van Doornik CE, Ongkosuwito JV, Feron EJ, Kijlstra A. Differences between intraocular and serum antibody responses in patients with ocular toxoplasmosis. Am J Ophthalmol 1998;126:698-706.
43. Ronday MJ, Ongkosuwito JV, Rothova A, Kijlstra A. Intraocular anti- Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol 1999;127:294-300.
44. Paul M. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin Diagn Lab Immunol 1999;6:514-8.
45. Chapman DJ, Ashburn D, Ogston SA, Ho-Yen DO. The relationship between ocular toxoplasmosis and levels of specific toxoplasma antibodies. Epidemiol Infect 1999;122:299-303.
46. Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 1999;106:1554-63.
47. Bou G, Figueroa MS, Marti-Belda P, Navas E, Guerrero A. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol 1999;37:3465-8.
48. Roberts F, Roberts CW, Ferguson DJ, McLeod R. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol 2000;22:1-5.
49. Nagineni CN, Detrick B, Hooks JJ. Toxoplasma gondii infection induces gene expression and secretion of interleukin 1(IL-1), IL-6, granulocytemacrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect Immun 2000;68:407-10.
50. Garweg JG, Jacquier P, Boehnke M. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol 2000;38:996-1001.
51. Jones CD, Okhravi N, Adamson P, Tasker S, Lightman S. Comparison of PCR Detection Methods for B1, P30, and 18S rDNA Genes of T. gondii in Aqueous Humor. Invest Ophthalmol Vis Sci 2000;41:634-44.
52. Guimaraes AC, Kawarabayashi M, Nunes EV, Ferraz SN, Chiosini CB, Tolezano JE, et al. Experimental toxoplasmosis, and immunosuppression. Rev Hosp Clin Fac Med São Paulo 1997;52:316-20.
53. Garweg JG, Kuenzli H, Boehnke M. Experimental ocular toxoplasmosis in naive and primed rabbits. Ophthalmologica 1998;212:136-41.
54. Gormley PD, Pavesio CE, Luthert P, Lightman S. Retinochoroiditis is induced by oral administration of Toxoplasma gondii cysts in the hamster model. Exp Eye Res 1999;68:657-61.
55. Hu MS, Schwartzman JD, Lepage AC, Khan IA, Kasper LH. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation. Ocul Immunol Inflamm 1999;7:17-26.
56. Johnson MW, Greven GM, Jaffe GJ, Sudhalkar H, Vine AK. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 1997;104:48-57.
57. Parrat E, Brousse D, Cousin P, L'Herron F, Touameur S, Charpentier D, et al. Fuch's uveitic syndrome in a patient with ocular toxoplasmosis. J Fr Ophthalmol 1999;22:1067-71.
58. Moraes Jr HV. Punctate outer retinal toxoplasmosis in an HIV-positive child. Ocul Immunol Inflamm 1999;7:93-5.
59. Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A. Retinal detachment in ocular toxoplasmosis. Ophthalmology 2000;107:36-40.
60. Melamed J, Gus P, Alvarenga Z. Tratamento da toxoplasmose ocular na gestação. Rev Bras Oftalmol 1997;56:241-8.
61. Gormley PD, Pavesio CE, Minnasian D, Lightman S. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 1998;39:1171-5.
62. Hacker M, Richter R, Gumbel H, Richter T, Ohrloff C. Toxoplasmosis retinochoroiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine]. Klin Monatsbl Augenheilkd 1998;212:84-7.
63. Rothova A, Bosch-Driessen LE, Van Loon NH, Treffers WF. Azithromicin for ocular toxoplasmosis. Br J Ophthalmol 1998;82:1306-8.
64. Melamed J. Tratamento da toxoplasmose ocular. Rev Bras Oftalmol 1998; 57:159-63.
65. Pearson PA, Piracha AR, Sen HA, Jaffe GJ. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 1999;106:148-53.
66. Belfort Jr R, Silveira C, Muccioli C, Horta BL, Victora C. Trimetoprim and sulfametoxazol for the prevention of toxoplasmic retinochoroiditis recurrences.[abstract 501]. Invest Ophthalmol Vis Sci 2000;41(Suppl 4 ):S95.